Macular Degeneration Research Fund
Age-Related Macular Degeneration (AMD) is the leading cause of irreversible blindness among individuals aged 55 years and older in developed countries. In addition to our retinal stem cell and retinal transplant research, our team has made significant contributions to clinical trials establishing vascular endothelial growth factor (VEGF) blockers as the new standard treatment for Wet-Age-Related Macular Degeneration. Your investment in retinal research today has tremendous influence on the care available tomorrow.
Give with confidence—Your gift is secure
We are committed to protecting your privacy
Times have changed. Technology now allows our voices to carry farther and our message to reach people we could never reach before.
If you believe, as we do, that the University of Nebraska Foundation's message is worth spreading and that our causes are worth supporting, please help us spread the word.